References:
  1. Mocarski E, Shenk T, Griffiths P, Pass RF. Cytomegaloviruses. In: Knipe DM, Howley PM, Eds. Field’s Virology , 6th ed. Philadelphia, PA, USA. Wolters Kluwer Lippincott Williams & Wilkins, 2013 :1960-2014.
  2. Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus prevalence and demographic characteristics associated with infection. Rev Med Virol. 2010 ; 20:202-213. doi: 10:1002/rmv.655. PMID: 20564615.
  3. Pass RF, Zhang C, Evans A, Simpson T, Andrews W, Huang M-I, Corey L, Hill J, Davis E, Flanigan C, Cloud G. Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med. 2009 ; 360:1191-1199. doi: 10.1056/NEJMoa0804749. PMID: 19297572.
  4. Lasry S, Dény P, Asselot C, Rauzu M, Boucher J, Guyot C, Leroux MC, Livartowski A, Reinert P, Nicolas JC. Interstrain variation in the cytomegalovirus (CMV) glycoprotein B gene sequence among CMV- infected children attending six day care centers. J Infect Dis.1996 ; 174:606-609. doi: 10.1093/infdis/174.3.606. PMID: 8769620.
  5. Staras SAS, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis. 2006 ; 43:1143-1151. doi: 10.1086/508173. PMID: 17029132.
  6. Kumar A, Coquard L, Pasquereau S, Russo L, Valmary-Deagano S, Borg C, Pothier P, Herbein G. Tumor control by human cytomegalovirus in a murine model of hepatocellular carcinoma. Mol Ther Oncolytics.2016; 3:16012. doi: 10.1038/mto.2016.12. PMID: 27626063.
  7. Herbein G, Nehme Zeina. Tumor control by cytomegalovirus: A door open for oncolytic virotherapy? Mol Ther Oncolytics. 2020; 17:1-8. doi: org/10.1016/J.omto.2020.03.004. PMID: 32300639.
  8. Massara L, Khairallah C, Yared N, Pitard V, Rousseau B, Izotte J, Giese A, Dubus Pierre, Gauthereau X, Déchanet-Merville J, Capone M. Uncovering the anticancer potential of murine cytomegalovirus and human colon cancer cells. Mol Ther Oncolytics. 2020 ; 16:250-261. doi: org/10.1016/j.omto.2020.01.007. PMID:32140563.
  9. Éboli LPdCB, Tannuri ACA, Tannuri U. Seropositivity for cytomegalovirus and PCR-EBV monitoring: Protective factors for posttransplant lymphoproliferative disorder in pediatric liver transplant. Pediatr Transplant. 2022 ; 26:e14226. doi: 10.1111/petr.14226. PMID: 35037358.
  10. Litjens NHR, Wagen Lvd, Kuball J, Kwekkeboom J. Potential beneficial effects of cytomegalovirus infection after transplantation. Front Immunol. 2018; 1;9:389. doi: 10.3389/fimmu.2018.00389. PMID: 29545802.
  11. Yu S-C, Ko K-Y, Teng S-C, Huang T-C, Lo H-T, Cheng C-L, Y M, Hong R-L, Chen C-N, Chen T-C, Yang T-L. A clinicopathological study of cytomegalovirus lymphadenitis and tonsillitis and their association with Epstein-Barr virus. Infect Dis Ther. 2021; 10:2661-2675. doi: org. 10.1007/s40121-021-00528-1. PMID: 34623624.
  12. Bigley AB, Baker FL, Simpson RJ. Cytomegalovirus: an unlikely ally in the fight against blood cancers? Clin Exp Immunol. 2018 ; 193:265-274. doi: 10.1111/cei.13152. PMID: 29737525.
  13. Janković M, Knežević A, Todorović M, Đunić I, Mihaljević B, Soldatović I, Protić J, Miković N, Stoiljković V, Jovanović T. Cytomegalovirus infection may be oncoprotective against neoplasms of B‑lymphocyte lineage: single‑institution experience and survey of global evidence. Virol J. 2022 ; 19:155. doi: 10.1186/s12985-022-01884-1. PMID: 36171605.
  14. Kann L, Kinchen SA, Williams BI, Ross JG, Lowry R, Hill CV, Grunbaum JA, Blumson PS, Collins JL, Kolbe JL. Youth risk behavior surveillance – United States, 1977. MMWR CDC Surveill Summ.1998 ; 47:1-89. PMID: 9719790.
  15. Halpern CT, Hallfors D, Bauer DJ, Iritani B, Waller MW, Cho H. Implications of racial and gender differences in patterns of adolescent risk behavior for HIV and other sexually transmitted diseases. Perspect Sex Reprod Health. 2004 ; 36:239-247. doi: 10.1363/psrh.36.239.04. PMID: 15687082.
  16. Markides K, Coreil J. The health of Hispanics in the southwestern United States: an epidemiologic paradox. Public Health Rep.1986 ; 101:253-265. PMID: 3086917.
  17. Chen H, Wu AH, Wang S, Bookstein A, Le Marchand L, Wilkens LR, Haiman CA, Cheng I, Monroe KR, Setiawan VW. Cancer Mortality Patterns by Birthplace and Generation Status of Mexican Latinos: The Multiethnic Cohort. J Natl Cancer Inst. 2022; 114:959-968. doi: 10.1093/jnci/djac078. PMID: 35404450.
  18. Graham C, Metayer C, Morimoto LM, Wiemels JL, Siddique A, Di M, Rodwin RL, Kadan-Lottick N, Ma X, Wang R. Hispanic Ethnicity Differences in Birth Characteristics, Maternal Birthplace, and Risk of Early-Onset Hodgkin Lymphoma: A Population-Based Case-Control Study. Cancer Epidemiol Biomarkers Prev. 2022 ; 31:1788-1795. doi: 10.1158-9965.EPI-22-0335. PMID: 35709749.
  19. Oluwasegun A, Abodurnin F, Nasef KE, Akinwumi B, Akinyemi I, Oni O, Fakorede M. IBCL-462 Racial-Ethnicity Gap in Survival among Non-Hodgkin Lymphoma Survivors. Clin Lymphoma Myeloma Leuk.2022 ; Suppl. 2: S393. doi: 10.1016/S2152-2650(22)01566-X. PMID: 36164118.
  20. Diaz Ayllon KE, Mowitz M. The Hispanic Paradox among Texas Newborns. Pediatrics. 2019 ; 144 (2_Meeting Abstract): 690. doi: 10.1542/peds.144.2MA7.690.
  21. Blansky D, Fazzari M, Mantzaris I, Rohan T, Hosgood HD 3rd. Racial and ethnic differences in all-cause mortality among Hispanics diagnosed with follicular lymphoma and chronic lymphocytic leukemia in Bronx, NY. Cancer Causes Control.2022 ; 33:137-147. doi: 10.1007/s10552-021-01507-0. PMID: 34677741.
  22. Pinheiro PS, Sherman RL, Trapido EJ, Fleming LE, Huang Y, Gomez-Marin O, Lee D. Cancer incidence in first generation U.S. Hispanics: Cubans, Mexicans, Puerto Ricans, and new Latinos. Cancer Epidemiol Biomarkers Prev. 2009 ; 18:2162-2169. doi: 10.1158/1055-9965.EPI-09-0329. PMID: 19661072.
  23. Nicolle LE, Minuk GY, Postl B, Ling N, Madden DL, Hoofnagle JH. Cross-sectional seroepidemiologic study of the prevalence of cytomegalovirus and herpes simplex virus infection in a Canadian Inuti (Eskimo) community. Scand J Infect Dis. 1986 ; 18:19-23. doi: 10.3109/00365548609032301. PMID: 3008308.
  24. Preiksaitis JK, Larke RP, Froese GJ. Comparative seroepidemiology of cytomegalovirus infection in the Canadian Arctic and an urban center. J Med Virol. 1988 ; 24:299-307. doi: 10.1002/jmv.1890240307. PMID: 2835426.
  25. Geris JM, Spector LG, Pfeiffer RM, Limaye AP, Yu KJ, Engels EA. Cancer risk associated with cytomegalovirus infection among solid organ transplant recipients in the United States. Cancer. 2022 ; 128:3985-3994. doi: 10.1002/cncr.34462. PMID: 36126024.
  26. SEER 12 (2000 Census Data). U.S. Bureau of Census 2020 , DEC Registrating data (PL 94-171), Tables P1, P2.
  27. Incidence - North American Association of Central Cancer Registries, ©2020 American Cancer Society, Inc. Surveillance Research.
  28. Zuhair M, Smit GSA, Wallis G, Jabbar F, Smith C, Devleesschauwer B, Griffiths P. Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis. Rev Med Virol.  2019 ; 29(3):e2034. doi: 10.1002/rmv.2034. PMID: 30706584.
  29. Simanek AM, Dowd JB,  Pawelec G, Melzer D, Dutta A,  Aiello AE. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One. 2011; 6(2):e16103. doi: 10.1371/journal.pone.0016103. PMID: 21379581.
  30. Schwaltz HN, Fried PL, Xue, Q-L, Walston J, Leng SX, Semba RD, Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc.2005; 53:747-754. doi: 10.111/j1532-5415.2005.53250.x. PMID: 15877548.
  31. Noppert GA, AielloAE, O’Rand AM,Cohnen HJ. Race/ethnic and educational disparities in the association between pathogen and educational disparities in the association between pathogen burden and laboratory-based cumulative deficit index. J Racial Ethn Health Disparities. 2020; 7:99-108. doi: 10.1007/s40615-019-00638-0. PMID: 31642044.
  32. Fowler K, Mucha J, Neuman M, Lewandowski W. Kaczanovska M, Grys J. Schmid E, Natenshon S. Talarico C, Buck PO, Diaz-Decaro J. A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development. BMC Public Health. 2022 ; 22:1659 (15pp ). doi: 10.1186/s12889-022-13971-7. PMID: 36050659.
  33. Bate SL, Dollard SC, Cannon MJ, Cytomegalovirus seroprevalence in the United States: The national Health and Nutritional Examination Surveys, 1988-2004. Clin Infect Dis. 2010 ; 50: 1439-1447. doi: 10.1086/652438. PMID: 20426575.
  34. National Center for Health Statistics, Plan and Operation of the Third National Health and Nutrition Examination Survey 1988-94. Series 1: programs and collection procedures. Vital Health Stat I 1994 ; 32:1-407. Available at: http://www.cdc.gov/nchs/data/series/sr_01/sr01_032.pdf.
  35. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey: Documentation 2009 , http://www.cdc.gov/nchs/nhanes/vardemo_b.htm. Accessed 12 April 2010 by Bate et al. 2010 [33].
  36. U. S. Census Bureau. Census 2000 Summary File 2, Table PCT27, United States, Washington, DC: U.S. Census Bureau, 2008 .
  37. Centers for Disease Control and Prevention, Analytic and Reporting Guidelines. The Third National Health and Nutrition Examination Survey. NHANES III (1988-1994). Hyattsville, MD: National Center for Health Statistics, 1996 . Available at: https://www.cdc.gov/nchs/data/nhanes/nhanes3/nh3gui.pdf.
  38. Surveillance, Epidemiology, and End Results (SEER) Program.SEER*Stat Database: Incidence-SEER 18 Registries Research Data+ Hurricane Katrina Impacted Louisiana Cases, November 2020 Submission (2000-2018), Katrina/Rita Population Adjustment. Linked to County Attributes-Total U.S., 1969-2018 Counties. National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance System Branch;2021 .
  39. Surveillance Research Program. SEER*Explorer: an interactive website for SEER cancer statistics. National Cancer Institute;2021 . Accessed April 15, 2021. seer.cancer.gov/explorer/
  40. Surveillance, Epidemiology, and End Results (SEER) Program.SEER*Stat Database: Incidence-SEER Research Limited-Field Data with Delay-Adjustment, 21Registries, Malignant Only, November 2020 Submission (2000-2018)-Linked to County Attributes-Time Dependent (1990-2018) Income/Rurality; 1969-2019 Counties. National Cancer Institute, Division of Cancer Control and population Sciences, Surveillance Research Program; 2021 .
  41. Surveillance, Epidemiology, and End results (SEER) Program.SEER*Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence Data-Cancer in North America Analytic File, 1995-2018, With Race/Ethnicity; Custom File With County; American Cancer Society Facts and Figures Projection Project (which includes data from the Center for Disease Control and Prevention’s national Program of Cancer Registries, the Canadian Council of Cancer Registries’ Provincial and territorial Registries, and the national Cancer Institute’s SEER Registries, certified by the NAACCR as meeting high-quality incidence data standards for the specified time periods). National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program; 2021 .
  42. Sherman R, Firth R, Charlton M, et al. Eds. Cancer in North America: 2014-2018. Volume Two: Registry-Specific Cancer Incidence in the United States and Canada. North American Association of Central Cancer registries, Inc; 2021 .
  43. Zhu J, Davidson M, Leinoven M, Saikku P, Gaydos CA, Canos DA, Gutman KA, Howard BV, Epstein SE, GOCADAN Study Investigators.Prevalence and persistence of antibodies to herpes viruses, Chlamydia pneumonia, and Helicobacter pylori in Alaskan Eskimos: the GOCADAN Study. Clin Microbiol Infect 2006 ; 12:118-122. doi: 10.1111/j.1469-0691.2005.01319.x. PMID: 16441448.
  44. Henley SJ, Ward EM, Scott S, Ma J, Anderson RN, Firth AU, Thomas CC, Islami F, Weir HK, Lewis DR, Sherman RL, Wu M, Benard VB, Richardson LC, Jemal A, Cronin K, Kohler BA. Annual Report to the Nation on the status of Cancer, Part I : national Cancer Statistics. Cancer2020 ; 126:2225-2249. doi: 10.1002/cncr.32802. PMID: 32162336.
  45. Cronin KA, Scott S, Firth AU, Sung H, Henley SJ, Sherman RL, Siegel RL, Anderson RN, Kohler BA, Benard VB, Negoita S, Wiggins C, Cance WC, Jemal A. Annual report to the nation on the status of cancer, part 1: National cancer statistics. Cancer 2022 ; 128:4251-4284. doi: 10.1002/cncr.34479. PMID: 36301149.
  46. Miller BA, Chu KC, Hankey BF, Ries LAG. Cancer incidence and mortality patterns among specific Asian and pacific Islander populations in the U. S. [Appnxs. 1&2, Tabs. 2-4], Cancer Causes Control2008; 19:227-256. doi: 10.1007/s10662-007-9088-3. PMID: 18066673.
  47. U. S. Department of Health and Human Services (HHS) (2000). Healthy people 2010 , 2nd ed. With understanding and improving health and objectives for improving health, 2 vols. U. S. Government Printing Office, Washington.
  48. Rubicz R, Zhu J, Laston S, Cole SA, Voruganti VS, Ebbesson SOE, Howard BV, MacCluer JW, Davidson M, Umans JG, Comuzzie AG, Göring HHH. Statistical genetic analysis of serological measures of common, chronic, infections in Alaska Native participants in the GOCADAN study. Genet Epidemiol 2013 ; 37:751-757. doi: 10.1002/gepi.21745. PMID: 23798484.
  49. U. S. Department of Health and Human Services (HHS), National Institutes of Health 2007 . Strategic research plan to reduce and ultimately eliminate health disparities, vol. 1. Available from http://ncmhd.nih.gov/our_programs/strategic/index.asp. Accessed Sept, 2007.
  50. National Cancer Institute SEER Limited-Use Data. Available from URL: http://www.seer.cancer.gov/data/. Tables I-20 and I-21, Figures I-13 and I-14.
  51. Sung H, Ferley J, Siegel, RL, Laverssanne I, Jemal, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer J Clin2021 ; 71:209-249. doi: 10.3322/caac.21660. PMID: 33538338.
  52. Conde-Glez C, Lazcano-Ponce E, Rojas R, DeAntonio R, Romano-Mazzotti L, Cervantes Y, Ortega-Barria E. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico. Vaccine 2013; 31:5067-5074. doi: 10.1016/j/vaccine.2013.08.077. PMID: 24021305.
  53. Furman D, Jojic V, Sharma S, Shen-Orr SS, Angel CJL, Onengut-Gumuscu S, Kidd BA, Maecker HT, Concannon P, Dekker CL, Thomas PG, Davis MM.2015 . Cytmegalovirus infection enhances the immune response to influenza. Sci. Transl. Md. 7:281ra43. doi: 10.1126/scitranslmed.aaa2293. PMID: 25834109.
  54. Lantos PM, Hoffman K, Permar SR, Jackson P, Hughes BL, Swamy GK. Geographic Disparities in Cytomegalovirus Infection During Pregnancy. Racial Ethn Health Disparities. 2018 ; 5:782-786. doi: 10.1007/s40616-017-0423-4. PMID: 28840519.
  55. Rook GAW. Evolution, the immune system, and the health consequences of socioeconomic inequality. mSystems. 2022 ; 7: e0143821. doi: 10.1128/msystems.01438-21. PMID: 35285679.
  56. Dowd JB, Palermo TM, Aiello AE. Family poverty is associated with cytomegalovirus antibody titers in U.S. children. Health Psychol.2012 ; 31:5-10. doi: 10.1037/a0025337. PMID: 21895.
  57. Dowd JB, Aiello AE, Alley DE. Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the U.S. population: NHANES III. Epidemiol Infect. 2009 ; 137:58-65. doi: 10.1017/S0950268808000551. PMID: 18413004.
  58. Lin L, Noone A-M, Gomez SL, Scoppa S, Gibson JT, Lichtensztajn D, Fish K, Wilkens LR, Goodman MT, Morris C, Kwong S, Deapen D, Miller BA. Cancer incidence trends among native Hawaiians and other pacific Islanders in the United States, 1990-2008. J Natl Cancer Inst.2013 ; 105:1086-1095. doi:10.1093/jnci/djt156. PMID: 23878354.
  59. Gomez SL, Noone A-M, Lichtensztajn DY, Scoppa S, Gibson JT, Liu L, Morris C, Kwong S, Fish K, Wilkens LR, Goodman MT, Deapen D, Miller BA. Cancer incidence trends among Asian-American population in the United States, 1990-2008. J Natl Cancer Inst. 2013 ; 105:1096-1110. doi: 10.1093/jnci/djt157. PMID: 23878350.
  60. Kolonel L, Wilkens LR, Migrant Studies. In: Eds. Schottenfeld D, Fraumeni JF Jr. Cancer Epidemiology and Prevention , 3rd ed. New York: Oxford University Press. 2006 ; 189-201.
  61. Bosetti C, Levi F, Ferlay J, Lucchini F, Negri E, La Vecchia C. Incidence and mortality from non-Hodgkin Lymphoma in Europe: The end of epidemics? Int J Cancer. 2008 ; 123:1917-1923. doi: doi.org/10.1002/ijc.23722. PMID: 18688859.
  62. Hoshiba T, Asamoto A, Yabuki Y. Decreasing seropositivity of cytomegalovirus of pregnant women in Japan. [Article in Japanese] Nihon Rinsho. 1998 ; 56:193-196. PMID: 9465689.
  63. Plotkin SA. Preventing infection by human cytomegalovirus. J Infect Dis. (Suppl. 1 Article). 2020 ; 221:S 123-127. doi:10.1093/infdis/jiz448. PMID: 32134484.
  64. Griffiths P, Plotkin S, Mocarski E, Pass R, Schleiss M, Krause P, Bialek S. Desirability and feasibility of a vaccine against cytomegalovirus. Vaccine. 2013 ; 31 (Suppl. 2): B197- B203. doi: 10.1016/j.vaccine.2012.10.074. PMID: 23598482.
  65. Espey DK, Wu X-C, Swan J, Wiggins C, Jim AJ, Ward E, Wingo PA, Howe HL, Ries LA, Miller BA, Jemal A, Ahmed F, Cobb N, Kaur JS, Edwards BK. Annual report to the nation on the status of Cancer, 1975-2004, Featuring Cancer in American Indians and Alaska Natives. Cancer2007 ; 110:2119-2152. doi:10.1002/cncr.23044. PMID: 17939129.
  66. Nikitin Yu P, Boichenko NS, Astakhova TI, Dokuchaev AT, Shubnikov EV. Cancer in Russian Inuit, Acta Oncologica. 1996 ; 35:617-619. doi:10.3109/02841869609096995. PMID: 8813070.
  67. Jenkins AL, Gyorkos TW, Culman KN, Ward BJ, Pekeles GS, Mills EL. An overview of factors influencing the health of Canadian Inuit infants, Int J Circumpolar Health. 2003 ; 62: 17-39, doi:10.3402/ijch.v62i1.17526. PMID: 12725339.
  68. Goplani SV, Janiz AE, Martinez SA, Gutman P, Khan S, Campbell JE. Trends in cancer incidence among American Indians and Non-Hispanic Whites in the United States, 1999-2015. Epidemiology. 2020 ; 31:205-215. doi: 10.1097/EDE.0000000000001140. PMID: 31764279.
  69. Langer-Gould A, Wu J, Lucas R, Smith J, Gonzales E, Amezcua L, Haraszti S, Chen LH, Quach H, James JA, Barcellos LF, Xiang AH. Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility. A Multiethnic Study. Neurology. 2017 ; 89:1330-1337. doi: 10.1212/WNL.0000000000004412. PMID: 28855411.
  70. Melkonian SC, Jim MA, Haverkamp D, Wiggins CL, McCollum J, White MC, Kaur JS, Espey DK. Disparities in cancer incidence and trends among American Indians and Alaska Natives in the United States, 2010-2015. Cancer Epidemiol Biomarkers Prev. 2019 ; 28:1604-1611. doi: 10.1058/1055-9965.EPI-19-0288. PMID: 31575554.
  71. Leung J, Kennedy JL, Haberling DL, Apostolou A, Lanzieri T. Congenital CMV-coded diagnosis among American Indian and Alaska Native infants in the United States, 2000-2017. 2020 ; 22:1101-1104. doi: 10.1007/s10903-020-01024-3. PMID: 32424641.
  72. Lanzieri TM, Kruszon-Moran D, Amin MM, Bialek SR, Cannon MJ, Dollard SC. Seroprevalence of cytomegalovirus among children 1 to 5 years of age in the United States from the National Health and Nutrition Examination Survey of 2022 to 2012. Clin Vaccine Immunol.2015 ; 22:245-247. doi: 10.1128/CVI.00697-14. PMID: 25520150.
  73. Kelly JJ, Lanier AP, Alberts S, Wiggins CL. Differences in cancer incidence among Indians in Alaska and New Mexico and U.S. Whites, 1993-2002. Cancer Epidemiol Biomarkers Prev. 2006 ; 15:1515-1519. doi: 10.1058/1055-9965.EPI-05-0454. PMID: 16896042.
  74. US Census Bureau. The American community – Pacific Islanders 2004 . American community survey reports. http:// www. census.gov/prod/2007pubs/acs-06.pdf. Accessed September 1,2012 .
  75. National Cancer Institute, Surveillance Epidemiology and End Result. http://seer.cancer.gov/about. Accessed September 1,2012 .
  76. Haverkamp D, Melkonian SC, Jim MA, Growing disparity in the incidence of colorectal cancer among non-Hispanic American Indian and Alaska native populations – United States, 2013-2017. Cancer Epidemiol Biomarkers Prev. 2021 ; 30:1799-1806. doi: 10.1158/1055-9965.EPI-21-0343. PMID:34341050.
  77. Wiggins CL, Espey DK, Wingo PA, Kaur JS, Wilson RT, Swan J, Miller BA, Jim MA, Kelly JJ, Lanier AP. Cancer among American Indians and Alaska Natives in the United States, 1999-2004. Cancer Supplement.2008 ; 113:1142-1152. doi: 10.1002/cncr.23734. PMID: 18720375.
  78. Badami KG, McQuilkan Bickerwstaffe S, Wells JE, Parata M. Cytomegalovirus seroprevalence and ‘cytomegalovirus-safe’ seropositive blood donors. Epidemiol Infect 2009 ; 137:1776-1780. doi: 10.1017/90950268809990094. PMID: 19480727.
  79. Zamora SM, Pinheiro PS, Lin Gomez S, Hastings KG, Palaniappan LP, Hu J, Thompson CA. Disaggregatuing Hispanic American cancer mortality burden by detailed ethnicity. Cancer Epidemiol Biomarkers Prev.2019 ; 28:1353-1363. doi: 10.1158/1055-9965. PMID: 31147314.
  80. Swan J, Edwards BK. Cancer rates among American Indians and Alaska Natives. Cancer. 2003 ; 98:1262-1277. doi: 10.1002/cncr.11633. PMID: 12973851.
  81. Crocombe RG (2007). Asia in the Pacific Islands: Replacing the West. (p .13) Suva IPS Publications, University of the South Pacific. Institute of Pacific Studies. ISBN 978 982 02 0388 4.
  82. Goodrum F. Human cytomegalovirus latency: approaching the Gordian Knot. Annu Rev Virol. 2016 ; 3:333-337. doi:10.1146/annurev-virology-110615-042422. PMID: 27501258.
  83. Griffiths P, Babunian C, Ashby D. The demographic characteristics of pregnant women infected with cytomegalovirus. Int J Epidemiol.1985 ; 14:447-452. doi: 10.1093/ije/14.3.447. PMID: 2997052.
  84. Becker TM, Magder L, Harrison HR, Stewart JA, Humphrey DD, Hauler J, Nahmias AJ. The epidemiology of infection with the human herpesviruses in Navajo children. Am J Epidemiol. 1988 ; 127:1071-1078. doi: 10.1093/oxfordjournals.aje.a114883. PMID: 2833854.
  85. Sorem KA. Cancer incidence in Zuni Indians of New Mexico. Yale J Biol Med. 1985 ; 58: 489-496. PMID: 4090535.